MC2 Therapeutics A/S Completes Enrollment of EU Phase 3 Head-to-Head Study in Patients With Plaque Psoriasis Treated With MC2-01 PADTM Cream
COPENHAGEN, Denmark--(BUSINESS WIRE)--Aug 7, 2019--
COPENHAGEN, Denmark--(BUSINESS WIRE)--Aug 7, 2019--